These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1163 related items for PubMed ID: 20236348

  • 1. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X, Fang Y, Liang J, Yin Z, Miao J, Luo N.
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [Abstract] [Full Text] [Related]

  • 2. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
    Knight YE, Edvinsson L, Goadsby PJ.
    Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
    [Abstract] [Full Text] [Related]

  • 3. 5-HT7 Receptors Are Not Involved in Neuropeptide Release in Primary Cultured Rat Trigeminal Ganglion Neurons.
    Wang X, Hu R, Liang J, Li Z, Sun W, Pan X.
    J Mol Neurosci; 2016 Jun; 59(2):251-9. PubMed ID: 26892478
    [Abstract] [Full Text] [Related]

  • 4. 5-HT7 receptors are involved in neurogenic dural vasodilatation in an experimental model of migraine.
    Wang X, Fang Y, Liang J, Yan M, Hu R, Pan X.
    J Mol Neurosci; 2014 Jun; 54(2):164-70. PubMed ID: 24584680
    [Abstract] [Full Text] [Related]

  • 5. Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans.
    Classey JD, Bartsch T, Goadsby PJ.
    Brain Res; 2010 Nov 18; 1361():76-85. PubMed ID: 20833155
    [Abstract] [Full Text] [Related]

  • 6. Primary trigeminal afferents are the main source for stimulus-induced CGRP release into jugular vein blood and CSF.
    Hoffmann J, Wecker S, Neeb L, Dirnagl U, Reuter U.
    Cephalalgia; 2012 Jul 18; 32(9):659-67. PubMed ID: 22652383
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Functional immunohistochemistry of neuropeptides and nitric oxide synthase in the nerve fibers of the supratentorial dura mater in an experimental migraine model.
    Knyihár-Csillik E, Tajti J, Chadaide Z, Csillik B, Vécsei L.
    Microsc Res Tech; 2001 May 01; 53(3):193-211. PubMed ID: 11301495
    [Abstract] [Full Text] [Related]

  • 10. Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model.
    Knyihár-Csillik E, Tajti J, Samsam M, Sáry G, Slezák S, Vécsei L.
    J Neurosci Res; 1997 Jun 01; 48(5):449-64. PubMed ID: 9185668
    [Abstract] [Full Text] [Related]

  • 11. The effects of the 5-HT(6) receptor agonist EMD and the 5-HT(7) receptor agonist AS19 on memory formation.
    Meneses A, Perez-Garcia G, Liy-Salmeron G, Flores-Galvez D, Castillo C, Castillo E.
    Behav Brain Res; 2008 Dec 16; 195(1):112-9. PubMed ID: 18191236
    [Abstract] [Full Text] [Related]

  • 12. Involvement of 5-HT₇ receptors in the pathogenesis of temporal lobe epilepsy.
    Yang Z, Liu X, Yin Y, Sun S, Deng X.
    Eur J Pharmacol; 2012 Jun 15; 685(1-3):52-8. PubMed ID: 22543085
    [Abstract] [Full Text] [Related]

  • 13. Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons.
    Buldyrev I, Tanner NM, Hsieh HY, Dodd EG, Nguyen LT, Balkowiec A.
    J Neurochem; 2006 Dec 15; 99(5):1338-50. PubMed ID: 17064360
    [Abstract] [Full Text] [Related]

  • 14. [Suppressing effect of the serotonin 5HT1B/D receptor agonist rizatriptan on calcitonin gene-related peptide (CGRP) concentration in migraine attacks].
    Stepień A, Jagustyn P, Trafny EA, Widerkiewicz K.
    Neurol Neurochir Pol; 2003 Dec 15; 37(5):1013-23. PubMed ID: 15174248
    [Abstract] [Full Text] [Related]

  • 15. Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats.
    Ma QP, Hill R, Sirinathsinghji D.
    Eur J Neurosci; 2001 Jun 15; 13(11):2099-104. PubMed ID: 11422450
    [Abstract] [Full Text] [Related]

  • 16. mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene-related peptide in the rat trigeminovascular system.
    Amrutkar DV, Ploug KB, Hay-Schmidt A, Porreca F, Olesen J, Jansen-Olesen I.
    Pain; 2012 Apr 15; 153(4):830-838. PubMed ID: 22305629
    [Abstract] [Full Text] [Related]

  • 17. An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system.
    Limmroth V, Katsarava Z, Liedert B, Guehring H, Schmitz K, Diener HC, Michel MC.
    Pain; 2001 May 15; 92(1-2):101-6. PubMed ID: 11323131
    [Abstract] [Full Text] [Related]

  • 18. Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine.
    Levy D, Burstein R, Strassman AM.
    Ann Neurol; 2005 Nov 15; 58(5):698-705. PubMed ID: 16240341
    [Abstract] [Full Text] [Related]

  • 19. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
    Bellamy JL, Cady RK, Durham PL.
    Headache; 2006 Jan 15; 46(1):24-33. PubMed ID: 16412148
    [Abstract] [Full Text] [Related]

  • 20. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
    Hoskin KL, Goadsby PJ.
    Exp Neurol; 1998 Mar 15; 150(1):45-51. PubMed ID: 9514827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.